Incidence of herpes simplex virus type 2 infections in Africa: a systematic review.

PubWeight™: 0.87‹?›

🔗 View Article (PMC 4281803)

Published in Open Forum Infect Dis on July 11, 2014

Authors

Sharanya Rajagopal1, Amalia Magaret2, Nelly Mugo3, Anna Wald4

Author Affiliations

1: Departments of Epidemiology.
2: Laboratory Medicine ; Biostatistics ; Vaccine and Infectious Disease Division , Fred Hutchinson Cancer Research Center , Seattle, Washington.
3: Departments of Global Health ; Medicine , University of Washington , Seattle, Washington ; Department of Obstetrics and Gynaecology , University of Nairobi , Kenya ; Department of Obstetrics and Gynaecology , Kenyatta National Hospital , Nairobi , Kenya.
4: Departments of Epidemiology ; Laboratory Medicine ; Vaccine and Infectious Disease Division , Fred Hutchinson Cancer Research Center , Seattle, Washington ; Medicine , University of Washington , Seattle, Washington.

Articles cited by this

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science (2010) 35.19

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ (2009) 34.99

Impact of stepping stones on incidence of HIV and HSV-2 and sexual behaviour in rural South Africa: cluster randomised controlled trial. BMJ (2008) 7.63

Syndromic management of sexually-transmitted infections and behaviour change interventions on transmission of HIV-1 in rural Uganda: a community randomised trial. Lancet (2003) 6.77

Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis (2002) 5.09

Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med (2004) 5.04

Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA (2001) 4.54

Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial. JAMA (2004) 3.84

An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull World Health Organ (2008) 3.62

Epidemiology of herpes simplex virus type 2 infection in the developing world. Herpes (2004) 3.47

Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa. PLoS One (2008) 3.05

Herpes simplex virus type 2 infection increases HIV incidence: a prospective study in rural Tanzania. AIDS (2002) 2.93

The epidemiology of HSV-2 infection and its association with HIV infection in four urban African populations. AIDS (2001) 2.87

Efficacy results of a trial of a herpes simplex vaccine. N Engl J Med (2012) 2.77

Performance of commercially available enzyme immunoassays for detection of antibodies against herpes simplex virus type 2 in African populations. J Clin Microbiol (2004) 2.55

Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women. Clin Infect Dis (2012) 2.55

Logistic regression when the outcome is measured with uncertainty. Am J Epidemiol (1997) 2.49

Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women. AIDS (2007) 2.44

Estimating incidence from prevalence in generalised HIV epidemics: methods and validation. PLoS Med (2008) 2.42

Incident and prevalent herpes simplex virus type 2 infection increases risk of HIV acquisition among women in Uganda and Zimbabwe. AIDS (2007) 2.35

Timing is everything: international variations in historical sexual partnership concurrency and HIV prevalence. PLoS One (2010) 2.32

Effect of HSV-2 serostatus on acquisition of HIV by young men: results of a longitudinal study in Orange Farm, South Africa. J Infect Dis (2009) 2.23

Knowledge of partners' genital herpes protects against herpes simplex virus type 2 acquisition. J Infect Dis (2006) 2.19

Seroprevalence and incidence of genital ulcer infections in a rural Ugandan population. Sex Transm Infect (1999) 2.03

HIV dynamics and behaviour change as determinants of the impact of sexually transmitted disease treatment on HIV transmission in the context of the Rakai trial. AIDS (2002) 1.77

Topical tenofovir, a microbicide effective against HIV, inhibits herpes simplex virus-2 replication. Cell Host Microbe (2011) 1.74

Disentangling contributions of reproductive tract infections to HIV acquisition in African Women. Sex Transm Dis (2009) 1.73

Increasing prevalence of genital herpes in developing countries: implications for heterosexual HIV transmission and STI control programmes. Sex Transm Infect (1999) 1.64

Factors associated with the prevalence and incidence of herpes simplex virus type 2 infection among men in Rakai, Uganda. J Infect Dis (2009) 1.61

Seroprevalence and incidence of sexually transmitted diseases in a rural Ugandan population. Int J STD AIDS (1995) 1.54

Circumcision status and incident herpes simplex virus type 2 infection, genital ulcer disease, and HIV infection. AIDS (2012) 1.44

Prevalence and incidence of herpes simplex virus type 2 infection among male Zimbabwean factory workers. J Infect Dis (1999) 1.44

Associations between childhood adversity and depression, substance abuse and HIV and HSV2 incident infections in rural South African youth. Child Abuse Negl (2010) 1.43

Decline in sexually transmitted infection prevalence and HIV incidence in female barworkers attending prevention and care services in Mbeya Region, Tanzania. AIDS (2006) 1.37

Predictors of herpes simplex virus type 2 prevalence and incidence among bar and hotel workers in Moshi, Tanzania. J Infect Dis (2007) 1.33

Synergistic interactions between herpes simplex virus type-2 and human immunodeficiency virus epidemics. Herpes (2004) 1.30

No impact of oral tenofovir disoproxil fumarate on herpes simplex virus shedding in HIV-infected adults. AIDS (2011) 1.22

Factors associated with herpes simplex virus type 2 incidence in a cohort of human immunodeficiency virus type 1-seronegative Kenyan men and women reporting high-risk sexual behavior. Sex Transm Dis (2011) 1.12

Herpes simplex virus type-2 assay specificity and male circumcision to reduce herpes simplex virus type-2 acquisition. AIDS (2013) 1.11

Daily oral emtricitabine/tenofovir preexposure prophylaxis and herpes simplex virus type 2 among men who have sex with men. PLoS One (2014) 1.09

Population-level effect of potential HSV2 prophylactic vaccines on HIV incidence in sub-Saharan Africa. Vaccine (2008) 1.08

A prospective study of risk factors for herpes simplex virus type 2 acquisition among high-risk HIV-1 seronegative women in Kenya. Sex Transm Infect (2009) 1.06

Increased incidence of genital herpes after HAART initiation: a frequent presentation of immune reconstitution inflammatory syndrome (IRIS) in HIV-infected patients. AIDS Patient Care STDS (2006) 0.99

Male circumcision and herpes simplex virus type 2 infection in female partners: a randomized trial in Rakai, Uganda. J Infect Dis (2011) 0.99

Can behavior change explain increases in the proportion of genital ulcers attributable to herpes in sub-Saharan Africa? A simulation modeling study. Sex Transm Dis (2002) 0.97

African women recently infected with HIV-1 and HSV-2 have increased risk of acquiring Neisseria gonorrhoeae and Chlamydia trachomatis in the Methods for Improving Reproductive Health in Africa trial. Sex Transm Dis (2011) 0.97

The relative contribution of viral and bacterial sexually transmitted infections on HIV acquisition in southern African women in the Methods for Improving Reproductive Health in Africa study. Int J STD AIDS (2011) 0.97

Epidemiology of genital herpes - recent advances. Eur J Dermatol (1999) 0.93

Determinants of generalized herpes simplex virus-2 epidemics: the role of sexual partner concurrency. Int J STD AIDS (2013) 0.93

Are women who work in bars, guesthouses and similar facilities a suitable study population for vaginal microbicide trials in Africa? PLoS One (2010) 0.92

The prevalence, incidence and risk factors of herpes simplex virus type 2 infection among pregnant Zimbabwean women followed up nine months after childbirth. BMC Womens Health (2010) 0.91

Daily acyclovir to decrease herpes simplex virus type 2 (HSV-2) transmission from HSV-2/HIV-1 coinfected persons: a randomized controlled trial. J Infect Dis (2013) 0.89

Seroprevalence, predictors and estimated incidence of maternal and neonatal Herpes Simplex Virus type 2 infection in semi-urban women in Kilifi, Kenya. BMC Infect Dis (2011) 0.86

Transmission of herpes simplex virus Type 2 among factory workers in Ethiopia. J Infect Dis (2004) 0.86

High prevalent and incident HIV-1 and herpes simplex virus 2 infection among male migrant and non-migrant sugar farm workers in Zambia. Sex Transm Infect (2011) 0.84

The effect of the vaginal diaphragm and lubricant gel on acquisition of HSV-2. Sex Transm Infect (2011) 0.83

Partner-concurrency associated with herpes simplex virus 2 infection in young South Africans. Int J STD AIDS (2013) 0.79

Effect of HSV-2 on population-level trends in HIV incidence in Uganda between 1990 and 2007. Trop Med Int Health (2013) 0.78